Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review

Type 2 Diabetes

The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome

Diabetes Care.

Kakoly NS, Earnest A, Teede HJ, Moran LJ, Joham AE

doi: 10.2337/dc18-1738.

Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery

Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome

J Clin Endocrinol Metab.

Rubin KH, Glintborg D, Nybo M, Abrahamsen B, Andersen M

doi: 10.1210/jc.2017-01354.

COMMENTED

Diabetes and Pregnancy

Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial

Lancet Diabetes Endocrinol.

Løvvik TS, Carlsen SM, Salvesen Ø, Steffensen B, Bixo M, Gómez-Real F, Lønnebotn M, Hestvold KV, Zabielska R, Hirschberg AL, Trouva A, Thorarinsdottir S, Hjelle S, Berg AH, Andræ F, Poromaa IS, Mohlin J, Underdal M, Vanky E

doi: 10.1016/S2213-8587(19)30002-6.

Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.

J Clin Endocrinol Metab.

Dunaif A

doi: 10.1210/jc.2015-3780

COMMENTED

Type 2 Diabetes

Deintensification in older patients with type 2 diabetes: a systematic review of approaches, rates and outcomes

Diabetes Obes Metab.

Seidu S, Topsever P, Hambling CE, Cos FX, Khunti K

doi: 10.1111/dom.13724.

COMMENTED

Thyroid

A Systematic Review and Meta-Analysis of Patient Preferences for Combination Thyroid Hormone Treatment for Hypothyroidism

Front Endocrinol (Lausanne).

Akirov A, Fazelzad R, Ezzat S, Thabane L, Sawka AM

doi: 10.3389/fendo.2019.00477.

Further Publications

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome

J Clin Endocrinol Metab

Fraser GL, Obermayer-Pietsch B, Laven J, Griesinger G, Pintiaux A, Timmerman D, Fauser BCJM, Lademacher C, Combalbert J, Hoveyda HR, Ramael S

doi: 10.1210/clinem/dgab320

COMMENTED

Type 2 Diabetes

Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis

Diabetes Obes Metab.

Toyama T, Neuen BL, Jun M, Ohkuma T, Neal B, Jardine M, Heerspink HL, Wong MG, Ninomiya T, Wada T, Perkovic V

doi: 10.1111/dom.

Diabetes - General

Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis

Diabetologia.

Bhatia D, Lega IC, Wu W, Lipscombe LL

doi: 10.1007/s00125-019-04995-7.

Related content

The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome

Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome

Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial

Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.

Deintensification in older patients with type 2 diabetes: a systematic review of approaches, rates and outcomes

A Systematic Review and Meta-Analysis of Patient Preferences for Combination Thyroid Hormone Treatment for Hypothyroidism

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome

Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis

Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis